<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03922191</url>
  </required_header>
  <id_info>
    <org_study_id>CHUB-Pauels</org_study_id>
    <nct_id>NCT03922191</nct_id>
  </id_info>
  <brief_title>Post-Surgical Mediastinitis Within the CHU Brugmann Hospital</brief_title>
  <official_title>Post-Surgical Mediastinitis: Retrospective Study of Cases Treated Within the CHU Brugmann Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre Wauthy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brugmann University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mediastinitis is an infectious complication that can occur after cardiac surgery. The
      incidence varies between 1 and 3% depending on the type of procedure and the patient's
      condition. The mortality of this severe postoperative complication rises from 10 to 35%,
      which makes it dreadful.

      The major risk factors reported are obesity, diabetes, and immunosuppressive therapy. There
      are other less important ones: age, coronary bypass grafting (especially if using the two
      internal mammary arteries), nosocomial pneumonia, dialysis, prolonged mechanical ventilation,
      long operative asepsis, undrained retro-sternally hematoma, prolonged pre-operative
      hospitalization...).

      Prevention is very important. The principle of asepsis must absolutely be respected. The use
      of prophylactic antibiotic therapy is recommended.

      The most commonly encountered organisms are Staphylococcus aureus, coagulase-negative
      Staphylococci and gram-negative bacilli.

      There are several treatment modalities that vary between centers and may be different
      depending on the surgical team's experience and the depth or extent of the infection. The
      common principles of these treatments are: antibiotic therapy and surgical debridement (the
      timing of which may vary). The timing and modalities of wound closure are subject to
      variations: immediate sternal closure with placement of multiple or delayed drains. Muscle
      flaps or large omentum transplant may be necessary if tissue loss is too important.

      The investigators propose to review their experience in the treatment of cardiac post-surgery
      mediastinitis at Brugmann University Hospital in the last 20 years in both adult and
      pediatric patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 12, 2019</start_date>
  <completion_date type="Actual">July 15, 2019</completion_date>
  <primary_completion_date type="Actual">July 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of the hospitalization</measure>
    <time_frame>20 years</time_frame>
    <description>Duration of the hospitalization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality at six months</measure>
    <time_frame>6 months</time_frame>
    <description>Mortality rate six months after mediastinitis diagnosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of recurrence</measure>
    <time_frame>20 years</time_frame>
    <description>Percentage of recurrence of mediastinitis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of re-hospitalization</measure>
    <time_frame>20 years</time_frame>
    <description>Percentage of re-hospitalizations caused by mediastinitis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of the antibiotic treatment</measure>
    <time_frame>20 years</time_frame>
    <description>Duration of the antibiotic treatment for mediastinitis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence of superinfection</measure>
    <time_frame>20 years</time_frame>
    <description>Presence of superinfection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Date of birth</measure>
    <time_frame>20 years</time_frame>
    <description>Demographic data : Date of birth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sex</measure>
    <time_frame>20 years</time_frame>
    <description>Demographic data : sex.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk factors</measure>
    <time_frame>20 years</time_frame>
    <description>Demographic data : presence of risk factors (obesity, diabetes...).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical intervention</measure>
    <time_frame>20 years</time_frame>
    <description>Name of the surgical intervention that caused the mediastinitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Germ identification</measure>
    <time_frame>20 years</time_frame>
    <description>Name of the germ causing the mediastinitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of treatment</measure>
    <time_frame>20 years</time_frame>
    <description>Name of the antibiotics used to treat the mediastinitis</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Mediastinitis</condition>
  <arm_group>
    <arm_group_label>Pediatric population</arm_group_label>
    <description>Infants diagnosed with cardiac post-surgery mediastinitis within the HUDERF Hospital within the last 20 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult population</arm_group_label>
    <description>Adults diagnosed with cardiac post-surgery mediastinitis within the CHU Brugmann Hospital within the last 20 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data extraction from medical files</intervention_name>
    <description>Data extraction from medical files</description>
    <arm_group_label>Adult population</arm_group_label>
    <arm_group_label>Pediatric population</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the CHU Brugmann (adults) and HUDERF (pediatric) Hospitals, treated for
        post-cardiac surgery mediastinitis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  post-cardiac surgery mediastinitis

          -  patients of the CHU Brugmann (adults) and HUDERF (pediatric) Hospitals

        Exclusion Criteria:

        - none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Pauels, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Brugmann</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Brugmann</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>July 15, 2019</last_update_submitted>
  <last_update_submitted_qc>July 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Brugmann University Hospital</investigator_affiliation>
    <investigator_full_name>Pierre Wauthy</investigator_full_name>
    <investigator_title>Medical Director of the Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mediastinitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

